Related Experiment Videos
Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors
Cancer Research
|June 11, 1975
Abstract:
The two-drug combination of cyclophosphamide plus adriamycin was found to be therapeutically potentiating against four different C3H mammary tumor lines, the B16 melanoma, the Ridgway osteogenic sarcoma, and the P388 leukemia. The potentiation was not schedule dependent.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Minors' rights to refuse medical treatment requested by their parents: remaining issues.
Journal of the American Academy of Nurse Practitioners·2002
Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasma.
Journal of chromatography. B, Biomedical sciences and applications·2001
Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.
Journal of the American Chemical Society·2001
PD-L1: Friend or Foe? The Dark Side of Photoprotection.
Cancer research·2026
A Markov model cost threshold analysis of potential hepatitis B virus cure regimens.
Clinical and translational gastroenterology·2026
Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Is there a role for palliative care in CAR T-cell therapy?
Current opinion in supportive and palliative care·2026